Correlations of m6A Methylation-Related lncRNAs with the Prognosis of Papillary Thyroid Carcinoma
Xiang Li,Zigang Ding,Yun Tong
DOI: https://doi.org/10.2147/ijgm.s449827
IF: 2.145
2024-03-05
International Journal of General Medicine
Abstract:Xiang Li, 1 Zigang Ding, 1 Yun Tong 2 1 Department of General Surgery, The Affiliated Hospital of Jiujiang University, Jiujiang, People's Republic of China; 2 Department of Pain, The Affiliated Hospital of Jiujiang University, Jiujiang, People's Republic of China Correspondence: Yun Tong, The Affiliated Hospital of Jiujiang University, No. 57 East Xunyang Road, Jiangxi, Jiujiang 332000, People's Republic of China, Email Purpose: Papillary thyroid carcinoma (PTC) is the most common subtype of thyroid cancer. Recurrence makes the prognosis for some patients with PTC worse. Increasing evidence have suggested that N6-methyladenosine (m 6 A) RNA methylation plays an important role in tumorigenesis. However, the significance of m 6 A-related lncRNAs in the malignant progression of PTC remains unknown. In this study, we explored the significance of M 6 A-related lncrnas in the malignant progression of PTC. Patients and Methods: Transcriptome and clinical data of PTC were achieved and integrated from The Cancer Genome Atlas (TCGA). Firstly, a Spearman correlation analysis was performed to obtain m 6 A RNA methylation-associated lncRNAs. Next, We constructed a prognostic signature and assessed the accuracy of the signature by receiver operating characteristic (ROC) curve and Kaplan Meier survival analyses. Furthermore, functional enrichment analysis was performed on the high- and low-risk groups. Finally, we determined prognostic gene expression in clinical samples using quantitative reverse transcription polymerase chain reaction (RT-qPCR). Results: We identified 56 differentially expressed lncRNAs associated with m 6 A RNA methylation. Univariate Cox and Least Absolute Shrinkage and Selection Operator (LASSO) regression analyses showed that the survival-related lncRNAs associated with m 6 A RNA methylation were detected, which showed superior calibration and discrimination. Moreover, the biological processes related to energy metabolism were significantly activated in the high-risk group. Finally, the co-expressed genes of lncRNAs in the risk model were significantly enriched in biological processes related to copper ion response. Finally, we validated the expression levels of three prognostic genes in clinical samples using RT-qPCR. Conclusion: Our study revealed m 6 A RNA methylation-associated lncRNAs were significantly associated with disease-free survival in patients with papillary thyroid cancer, which would improve our understanding of the relationship between m 6 A RNA methylation-associated lncRNAs and PTC. Keywords: Papillary thyroid carcinoma, m 6 a RNA methylation, lncrna, PROGNOSIS, disease-free survival Thyroid carcinoma (TC), with increasing incidence in recent years, is one of the most frequent endocrine neoplasia. 1 According to statistics in 2018, the global incidence of TC in women reached 10.2 per 100,000 people, accounting for 5.12% of all female malignancies. 2 TC can be divided into four types: papillary thyroid carcinoma (PTC), follicular thyroid carcinoma, medullary thyroid carcinoma, and anaplastic thyroid carcinoma. 3 PTC is the most common pathological type of thyroid cancer, accounting for about 70–90% of all thyroid cancers. 4,5 Although most PTC patients have a good prognosis, there are still more than 10% of patients who encounter tumor recurrence or metastasis in long-term follow-up. 6 These patients with metastases or relapses have a significantly higher mortality rate, and the difficulty of retreatment is increased. Therefore, it is necessary to find new potential recurrence-related markers. 7,8 N-6 methyladenosine (m 6 A) modification, the most dominant modification form of RNA in eukaryotic cells, 9 is a dynamic and reversible process regulated by a "writer" (methyltransferase), an "eraser" (demethylase) and a "reader" (binding protein). 10 The "writer" catalyzes the formation of m 6 A methylation, which is mainly composed of METTL3, METTL14, WTAP, KIAA1429, METTL16, RBM15, and ZC3H13; The "eraser" mediates the removal of M 6 A methylation, which consists of FTO and ALKBH5; The "reader" affects the biological function of mRNA by specifically recognizing methylated adenosine on mRNA, which is mainly composed of YTHDF1/2/3, YTHDC1/2, HNRNPA2B1, HNRNPC11, and HNRNPG. 11 Previous studies have shown that m 6 A methylation plays an important role in the occurrence and development of a variety of malignant tumors. 12,13 The mechanisms may involve many stages of gene expression, such as RNA splicing, maturation, translation, and degradat -Abstract Truncated-
medicine, general & internal